Aneni and team selected as winners of National Institute on Drug Abuse challenge award
YCSC Assistant Professor Uche Aneni and team members submitted a winning proposal to the 2023 National Institute on Drug Abuse (NIDA) Substance Use Prevention
Related Articles
Yale Pediatrics Poster Presenters at PAS 2024
Check out which of our faculty will be presenting posters at the 2024 Pediatric Academic Societies Meeting in Toronto, Canada.
Find Yale Pediatrics at the 2024 Pediatric Academic Societies (PAS) Meeting
Check out where our faculty will be presenting at the 2024 Pediatric Academic Societies Meeting in Toronto, Canada.
Yale Pediatrics Poster Presenters at PAS 2024
Check out which of our faculty will be presenting posters at the 2024 Pediatric Academic Societies Meeting in Toronto, Canada.
Find Yale Pediatrics at the 2024 Pediatric Academic Societies (PAS) Meeting
Check out where our faculty will be presenting at the 2024 Pediatric Academic Societies Meeting in Toronto, Canada.
State expands Bridgeport program that offers home visits to families of newborns: ‘A lifeline’
Called Family Bridge, the program is currently open to the families of newborns from…
be Well: Foods that carry the most allergy risk
Millions of adults and kids have food allergies. Allergist Dr. Stephanie Leeds from Greenwich Hospital and Yale New Haven Children’s Hospital talked about the foods…
State expands Bridgeport program that offers home visits to families of newborns: ‘A lifeline’
Called Family Bridge, the program is currently open to the families of newborns from…
5th Annual Richard A. Ehrenkranz Symposium
06/04/2024 event : For over three decades, Dr. Richard Ehrenkranz was a leader in neonatology at Yale and on a national level, and a much…
Type 1 on a GLP-1 Drug? Watch for Hypoglycemia and DKA
Explore GLP-1 agonists for weight loss in type 1 diabetes with caution. Understand potential risks like hypoglycemia and DKA, while balancing benefits for heart and…
Common antibiotic may be helpful in fighting respiratory viral
Yale researchers say that nasal application of neomycin shows promise in the prevention and treatment of respiratory viral infections